Skip to main content
. 2024 Feb 26;5(1):102911. doi: 10.1016/j.xpro.2024.102911

Figure 7.

Figure 7

Impact of chemogenetic inhibition on MLIN activity levels

(A) Example maximum intensity projection of an awake recording in a Sca1::PV mouse before (left) and after CNO application (intraperitoneal injection 3 mg/kg, right).

(B) Proportional change in neuronal activity in Sca1:: PV MLIN upon CNO i.p. application. scale bar in (A) 50 μm. All images reproduced from Pilotto et al., 2023.